AXSM
Axsome Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +8.7% · netto nieuwe posities -5.3% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 129 | +8 | 27.56M | $6.74B | +16 | −9 |
| Q1 2026 | 125 | +4 | 27.78M | $4.69B | +9 | −6 |
| Q4 2025 | 120 | +1 | 28.15M | $5.13B | +2 | — |
| Q3 2025 | 19 | 0 | 15.93M | $1.93B | +1 | −2 |
| Q2 2025 | 17 | -1 | 13.98M | $1.46B | — | −1 |
| Q1 2025 | 15 | +3 | 4.41M | $513.88M | +3 | — |
| Q4 2024 | 12 | +1 | 3.90M | $329.80M | +1 | — |
| Q3 2024 | 10 | 0 | 3.50M | $314.34M | — | — |
| Q2 2024 | 10 | — | 4.77M | $384.18M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 4.18M | +6.0% | $507.74M | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passief) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 3 | Wellington Management ✦ | 1.33M | +84.1% | $162.08M | 0.0% | ▲ Add | 6 | SEC ↗ ×7 |
| 4 | T. Rowe Price ✦ | 1.04M | +69.3% | $126.00M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Geode Capital Management ✦ (passief) | 997.70K | +0.8% | $121.19M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | State Street Global Advisors ✦ (passief) | 942.96K | -1.6% | $114.52M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 927.88K | -5.0% | $112.69M | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 8 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 9 | Adage Capital Partners ✦ | 445.00K | -0.5% | $54.05M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 10 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 11 | Marshall Wace ✦ | 378.02K | +566.5% | $45.91M | 0.1% | ▲ Add | 4 | SEC ↗ ×3 |
| 12 | D. E. Shaw & Co. ✦ | 296.29K | +47.6% | $35.98M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | Goldman Sachs Group ✦ | 224.14K | — | $27.22M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 14 | Citadel Advisors ✦ | 158.41K | +1063.2% | $19.24M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | Renaissance Technologies ✦ | 150.00K | +8.2% | $18.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 118.66K | -7.2% | $14.41M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 17 | Point72 Asset Management ✦ | 18.71K | -94.7% | $2.27M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 8.21K | Nieuw | $996,740 | 0.0% | New | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 5.74K | -81.2% | $697,244 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Two Sigma Investments | $996,740 | 0.0% |
Verlaten
| Norges Bank | $48.89M | was 0.0% |
| Bridgewater Associates | $11.20M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 408 houders, 37.64M aandelen, $6.10B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 10.00K aand · $2.09M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie